Stay updated on Ecztra 4: Tralokinumab Drug Interaction Clinical Trial

Sign up to get notified when there's something new on the Ecztra 4: Tralokinumab Drug Interaction Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ecztra 4: Tralokinumab Drug Interaction Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T23:00:28.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    4 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the study involving the investigation of tralokinumab on the metabolism of selected CYP substrates in adults with moderate-to-severe Atopic Dermatitis.
    Difference
    0.1%
    Check dated 2024-06-06T14:40:03.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for study participants, specifying inclusion and exclusion criteria such as age, diagnosis, and treatment history. This change provides more specific information about the requirements for participants in the clinical trial.
    Difference
    33%
    Check dated 2024-05-22T21:27:40.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:54:56.000Z thumbnail image

Stay in the know with updates to Ecztra 4: Tralokinumab Drug Interaction Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ecztra 4: Tralokinumab Drug Interaction Clinical Trial page.